The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Seattle Genetics Inc

Nasdaq: SGEN
Last

(U.S.) $52.97

Today's change0.00 0.00%
Updated July 27 4:00 PM EDT. Delayed by at least 15 minutes.
 

Seattle Genetics Inc

Nasdaq: SGEN
Last

(U.S.) $52.97

Today's change0.00 0.00%
Updated July 27 4:00 PM EDT. Delayed by at least 15 minutes.

Seattle Genetics Inc down slightly

Seattle Genetics Inc closed down just (U.S.)$0.00 Thursday to (U.S.)$52.97. Shares have lost 2.16% over the last five days, but are unchanged over the last year to date. This security has underperformed the S&P 500 by 3.85% during the last year.

Key company metrics

  • Open(U.S.) $54.97
  • Previous close(U.S.) $52.97
  • High(U.S.) $55.06
  • Low(U.S.) $52.56
  • Bid / Ask(U.S.) $32.83 / (U.S.) $54.04
  • YTD % change+0.38%
  • Volume1,178,514
  • Average volume (10-day)993,918
  • Average volume (1-month)1,573,394
  • Average volume (3-month)957,594
  • 52-week range(U.S.) $42.58 to (U.S.) $75.36
  • Beta2.39
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$1.43
Updated July 27 4:00 PM EDT. Delayed by at least 15 minutes.

Latest Company News

View more News

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2017Q4/2016Q3/2016Q2/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016
Revenue10910510695
Total other revenue--------
Total revenue10910510695
Gross profit97949585
Total cost of revenue12121110
Total operating expense168161139129
Selling / general / administrative38413533
Research & development1181089386
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-59-56-32-33
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-60-55-32-33
Income after tax-60-55-32-33
Income tax, total--------
Net income-60-55-32-33
Total adjustments to net income--------
Net income before extra. items-60-55-32-33
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-60-55-32-33
Inc. avail. to common incl. extra. items-60-55-32-33
Diluted net income-60-55-32-33
Dilution adjustment--------
Diluted weighted average shares142142141140
Diluted EPS excluding extraordinary itemsvalue per share-0.42-0.39-0.23-0.23
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share-0.42-0.39-0.23-0.23